Focus topics

Bangladesh produces Sinopharm vaccine

Sinopharm’s Chinese Covid vaccine will soon begin production in Bangladesh. As the Chinese news agency Xinhua reports, a declaration to this effect was already signed in Beijing and Dhaka on Monday during an online conference. According to the statement, pharmaceutical company Incepta will manufacture the Chinese vaccine in Bangladesh’s capital. According to the plan, a capacity of five million doses per month is targeted. Production is to start in three months.

Continue reading now

… and get free access to this Professional Briefing for a month.

Are you already a guest at the China.Table? Log in now


    Ma Ying-jeou meets with Beijing’s Taiwan envoy
    China criticizes AUKUS plans
    Tsai completes first US stop of her Americas tour
    Hong Kong: organ exchange with the mainland